Factors Associated With COVID-19 Vaccine Response in Transplant Recipients: A Systematic Review and Meta-analysisArticle Published on 2022-10-012022-11-15 Journal: Transplantation [Category] 진단, [키워드] 95% CI 95% confidence interval age Allogeneic calcineurin Cell combating Comorbidity coronavirus disease COVID-19 COVID-19 vaccination COVID-19 vaccines dose Effects Factor General population healthy control higher risk humoral Immunocompromised Immunosuppressant immunosuppressive inclusion criteria increased risk inhibitor inhibitors mammalian medication Meta-analysis much lower Organ transplant outcome pandemic performed pooled rate Population Rapamycin receiving recipient recipients regimen response review risk factor second dose Seroconversion seroconversion failure Steroids systematic review the vaccine Transplant Vaccine vaccine response [DOI] 10.1097/TP.0000000000004256 PMC 바로가기
A high level of vaccine knowledge increases people’s behavioral risks for contracting COVID-19 in JapanArticle Published on 2022-10-012022-11-16 Journal: Social science & medicine (1982) [Category] COVID19(2023년), SARS, 변종, [키워드] association Behavioral risk calculated calculator conducted confidence interval COVID-19 COVID-19 pandemic COVID-19 vaccine cross-sectional survey examined Follow-up increase Japan knowledge maintain microCOVID. moderate Odds ratio preventive measure quantitative assessment questionnaire risk SARS-COV-2 infection significantly higher the vaccine Transmission vaccination Vaccine variants of SARS-CoV-2 widespread [DOI] 10.1016/j.socscimed.2022.115256 PMC 바로가기
Antibody titers after a third dose of the SARS-CoV-2 BNT162b2 vaccine in immunocompromised adults in Greece: Is a fourth dose necessary?그리스의 면역 저하 성인에서 SARS-CoV-2 BNT162b2 백신 3차 접종 후 항체 역가: 4차 접종이 필요한가요?Article Published on 2022-10-012022-09-11 Journal: Journal of medical virology [Category] COVID19(2023년), MERS, SARS, 변종, 진단, [키워드] age anti-S Anti-spike antibody Antibody titers Autoimmune autoimmune diabete autoimmune diabetes Autoimmune disease average baseline BNT162b2 BNT162b2 mRNA BNT162b2 mRNA COVID-19 vaccine BNT162b2 vaccine change correlated COVID-19 Decline decrease diabetes dose Effectiveness fold Fold change Fold changes Greece humoral Humoral response IgG antibody titer IgG antibody titers IgG GMC Immunocompromised immunocompromised adult immunocompromised adults immunocompromised individual immunocompromised individuals immunogenicity Inflammatory inflammatory disease leukemia lymphoma mRNA of BNT162b2 Omicron variant Omicron variants postvaccination real-world data SARS-CoV-2 serum sample serum samples Sex significantly the SARS-CoV-2 the vaccine third dose vaccination Vaccine vaccine dose vulnerable population [DOI] 10.1002/jmv.27954 PMC 바로가기 [Article Type] Article
A SARS-CoV-2 oral vaccine development strategy based on the attenuated Salmonella type III secretion systemArticle Published on 2022-10-012022-11-15 Journal: Journal of Applied Microbiology [Category] COVID19(2023년), SARS, 변종, 진단, 치료기술, [키워드] administration Analysis antibody Antigen antigens attenuated Salmonella ΔhtrA-VNP Bacterial caused CD44 CD69 COVID-19 vaccine cytometric cytosol delivery effective element elicited Express expression Flow fluorescence microscopy Heterologous IgA IgG in vitro increase in Macrophage mixed bacterial preparations. mutant N-protein NTD Oral vaccine pathogenicity phenotype Plasmid promoter RBD S-protein Safe Salmonella SARS-CoV-2 SARS-CoV-2 antigen SARS-CoV-2 vaccine screened secrete secretion shown Significance Significant significant increase SPI-2 strain T-cell activation T3SS the vaccine type III Vaccine was used [DOI] 10.1111/jam.15720 PMC 바로가기
The next frontier in vaccine design: blending immune correlates of protection into rational vaccine designReview Published on 2022-10-012022-10-05 Journal: Current opinion in immunology [Category] COVID19(2023년), SARS, 변종, 비임상, 진단, [키워드] accelerate accelerated antibody Antibody binding canonical Community Complete death embedding immune correlate Immune profile Immunity immunological lack neutralization pathogen populations protective vaccines question raised severe disease the vaccine to define Vaccine Vaccine design Vaccine development Vaccines variants of concern Viral variants waned [DOI] 10.1016/j.coi.2022.102234 [Article Type] Review
Seroepidemiological study of factors affecting anti-spike IgG antibody titers after a two-dose mRNA COVID-19 vaccination in 3744 healthy Japanese volunteersArticle Published on 2022-09-292022-11-15 Journal: Scientific Reports [Category] 진단, [키워드] 1.26 Adverse reaction affecting age anti-S anti-S antibody anti-S IgG anti-Spike IgG antibody Antibody titer Antibody titers BNT162b2 vaccine conducted COVID-19 vaccination cross-sectional dose Effect elapsed Factor Factors female females Gender healthy healthy volunteer identify IgG antibody titer immunosuppressants immunosuppressive IQR Japanese magnitude median age mRNA mRNA-1273 mRNA-1273 vaccine Multiple positive questionnaire SARS-COV-2 infection significantly smoking tested the vaccine therapy vaccination Vaccine Volunteer [DOI] 10.1038/s41598-022-20747-x PMC 바로가기
Real-world effectiveness and protection of SARS-CoV-2 vaccine among patients hospitalized for COVID-19 in Xi’an, China, December 8, 2021, to January 20, 2022: A retrospective studyArticle Published on 2022-09-232022-11-15 Journal: Frontiers in Immunology [Category] SARS, 진단, [키워드] addition Admission analyzed attenuate blood biochemical Blood routine CD8 China Clinical features coagulation function coagulative collected COVID-19 dose doses Effectiveness elevated eosinophil eosinophils Epidemic evaluate had no Hospitalized IgG IgG level Kidney function Laboratory laboratory data laboratory findings liver lymphocyte Lymphocytes moderate Patient patients patients hospitalized percentage proportion Protective Retrospective study SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 vaccine severe symptom significantly specific antibody Subtypes symptoms of COVID-19 T cell T-lymphocytes the vaccine vaccination Vaccine vaccine dose virus with COVID-19 [DOI] 10.3389/fimmu.2022.978977 PMC 바로가기
Assessing the impact of the four COVID-19 variants and the vaccine coverage on mortality in Malta over 2 years: An observational case studyArticle Published on 2022-09-232022-11-16 Journal: Frontiers in Public Health [Category] SARS, 변종, [키워드] Alpha variant Assessing center CFR contributed Control Coverage COVID-19 disease Disease burden dominant Effect Effectiveness European Factor highest Intervention Malta Ministry of Health Mortality Mutation omicron original pandemic Post-vaccine prevention reported target the vaccine Transmissibility vaccination vaccination rates variant was obtained website Year [DOI] 10.3389/fpubh.2022.1018505 PMC 바로가기
Evolving trend change during the COVID-19 pandemicArticle Published on 2022-09-202022-11-16 Journal: Frontiers in Public Health [Category] SARS, 변종, [키워드] African caused country COVID-19 COVID-19 pandemic death disease driving early stage Epidemics epidemics evolve epidemiological Europe Factors feasibility First wave Geographic distribution highest indicated Infection initial Lineage lowest omicron pandemic Prevent provide public health public health measures reducing reduction in severity single vaccine South America spatiotemporal Spread spread of COVID-19 Structure the disease the vaccine Transmissibility vaccination vaccination rate Vaccinations Vaccine variant variants [DOI] 10.3389/fpubh.2022.957265 PMC 바로가기
Vaccine effectiveness against referral to hospital after SARS-CoV-2 infection in St. Petersburg, Russia, during the Delta variant surge: a test-negative case-control studyArticle Published on 2022-09-202022-11-16 Journal: BMC Medicine [Category] SARS, 변종, [키워드] adjusted age Analysis case-control study categories caused Complete Computed tomography conducted COVID-19 COVID-19 vaccination criteria delta variant effective Effectiveness Efficacy Final flat Gam-COVID-Vac globe hospital Hospital admission individual initial logistic regression model low-dose Lung injury lung involvement men oxygen saturation Patient Pneumonia primary analysis Probability protective effect Randomised trial real-world data Russia SARS-CoV-2 SARS-COV-2 infection second dose Sex symptomatic SARS-CoV-2 infection the disease the vaccine vaccination Vaccine vaccine effectiveness was collected with COVID-19 women [DOI] 10.1186/s12916-022-02509-8 PMC 바로가기